Published in Spine (Phila Pa 1976) on July 01, 2001
Can Prophylactic Foraminotomy Prevent C5 Palsy | NCT03023696
Anterior approach versus posterior approach for the treatment of multilevel cervical spondylotic myelopathy: a systemic review and meta-analysis. Eur Spine J (2013) 1.77
Efficacy of multilevel anterior cervical discectomy and fusion versus corpectomy and fusion for multilevel cervical spondylotic myelopathy: a minimum 5-year follow-up study. Eur Spine J (2012) 1.41
C5 palsy following anterior decompression and spinal fusion for cervical degenerative diseases. Eur Spine J (2010) 1.27
Anterior versus posterior surgery for multilevel cervical myelopathy, which one is better? A systematic review. Eur Spine J (2010) 1.23
Surgical approach to cervical spondylotic myelopathy on the basis of radiological patterns of compression: prospective analysis of 129 cases. Eur Spine J (2008) 1.13
Minimum 2-year outcome of cervical laminoplasty with deep extensor muscle-preserving approach: impact on cervical spine function and quality of life. Eur Spine J (2009) 1.12
Retrospective cohort study between selective and standard C3-7 laminoplasty. Minimum 2-year follow-up study. Eur Spine J (2007) 1.11
Impact of deep extensor muscle-preserving approach on clinical outcome of laminoplasty for cervical spondylotic myelopathy: comparative cohort study. Eur Spine J (2012) 1.10
Comparison of ventral corpectomy and plate-screw-instrumented fusion with dorsal laminectomy and rod-screw-instrumented fusion for treatment of at least two vertebral-level spondylotic cervical myelopathy. Eur Spine J (2009) 1.08
Neurological recovery after surgical decompression in patients with cervical spondylotic myelopathy - a prospective study. Int Orthop (2007) 1.06
Relevance of expandable titanium cage for the treatment of cervical spondylotic myelopathy. Eur Spine J (2012) 1.05
Importance of preserving the C7 spinous process and attached nuchal ligament in French-door laminoplasty to reduce postoperative axial symptoms. Eur Spine J (2007) 1.04
Cervical spondylotic myelopathy and radiculopathy treated by oblique corpectomies without fusion. Neurosurg Rev (2004) 1.02
Axial pain after posterior cervical spine surgery: a systematic review. Eur Spine J (2010) 1.01
Posterior surgery for cervical myelopathy: laminectomy, laminectomy with fusion, and laminoplasty. Asian Spine J (2008) 1.01
Post-laminectomy kyphosis in patients with cervical ossification of the posterior longitudinal ligament : does it cause neurological deterioration? J Korean Neurosurg Soc (2008) 1.00
Preservation of C7 spinous process does not influence the long-term outcome after laminoplasty for cervical spondylotic myelopathy. Int Orthop (2006) 0.96
Axial neck pain after cervical laminoplasty. J Korean Neurosurg Soc (2010) 0.92
Noncontiguous anterior decompression and fusion for multilevel cervical spondylotic myelopathy: a prospective randomized control clinical study. Eur Spine J (2010) 0.91
The incidence of C5-C6 radiculopathy as a complication of extensive cervical decompression: own results and review of literature. Neurosurg Rev (2004) 0.89
Anterior corpectomy versus posterior laminoplasty for multilevel cervical myelopathy: a systematic review and meta-analysis. Eur Spine J (2013) 0.89
Comparison of anterior approach versus posterior approach for the treatment of multilevel cervical spondylotic myelopathy. Eur Spine J (2015) 0.88
Laminoplasty techniques for the treatment of multilevel cervical stenosis. Adv Orthop (2012) 0.84
Posterior approach to the degenerative cervical spine. Eur Spine J (2003) 0.83
A new method to determine whether ossified posterior longitudinal ligament can be resected completely and safely: spinal canal "Rule of Nine" on axial computed tomography. Eur Spine J (2014) 0.83
Double-door laminoplasty in managing multilevel myelopathy: technique description and literature review. Neurosurg Rev (2007) 0.83
Prevalence of C5 nerve root palsy after cervical decompressive surgery: a meta-analysis. Eur Spine J (2015) 0.83
Measurement of volume-occupying rate of cervical spinal canal and its role in cervical spondylotic myelopathy. Eur Spine J (2013) 0.82
Anterior approaches for cervical spondylotic myelopathy: which? When? How? Eur Spine J (2015) 0.82
Surgical management of multilevel cervical spinal stenosis and spinal cord injury complicated by cervical spine fracture. J Orthop Surg Res (2014) 0.82
Operative outcomes for cervical myelopathy and radiculopathy. Adv Orthop (2011) 0.82
Degenerative cervical spinal stenosis: current strategies in diagnosis and treatment. Dtsch Arztebl Int (2008) 0.81
A prospective, randomised, controlled multicentre study comparing cervical disc replacement with anterior cervical decompression and fusion. Int Orthop (2014) 0.81
Limitation of activities of daily living accompanying reduced neck mobility after laminoplasty preserving or reattaching the semispinalis cervicis into axis. Eur Spine J (2007) 0.81
Operative techniques for cervical radiculopathy and myelopathy. Adv Orthop (2011) 0.80
Successful outcome of six-level cervicothoracic corpectomy and circumferential reconstruction: case report and review of literature on multilevel cervicothoracic corpectomy. Eur Spine J (2006) 0.80
Cervical laminectomy and instrumented lateral mass fusion: techniques, pearls and pitfalls. Eur Spine J (2013) 0.79
Changes in the cross-sectional area of deep posterior extensor muscles of the cervical spine after anterior decompression and fusion: 10-year follow-up study using MRI. Eur Spine J (2011) 0.79
Three-level anterior cervical discectomy and fusion in elderly patients with wedge shaped tricortical autologous graft: A consecutive prospective series. Indian J Orthop (2008) 0.78
Cervical spondylotic myelopathy: the prediction of outcome following surgical intervention in 93 patients using T1- and T2-weighted MRI scans. Eur Spine J (2015) 0.78
Prevalence of axial symptoms after posterior cervical decompression: a meta-analysis. Eur Spine J (2016) 0.77
C5 nerve root palsy following decompression of cervical spine with anterior versus posterior types of procedures in patients with cervical myelopathy. Eur Spine J (2016) 0.76
One stage laminoplasty and posterior herniotomy for the treatment of myelopathy caused by cervical stenosis with cervical disc herniation. Int J Clin Exp Med (2015) 0.75
Laminoplasty for cervical myelopathy. Global Spine J (2012) 0.75
Open Door Laminoplasty: Creation Of A New Vertebral Arch. Int J Spine Surg (2017) 0.75
Enlarged anterior cervical diskectomy and fusion in the treatment of severe localised ossification of the posterior longitudinal ligament. J Orthop Surg Res (2016) 0.75
Incidence and Risk Factors for Late Neurologic Deterioration after C3-C6 Laminoplasty for Cervical Spondylotic Myelopathy. Global Spine J (2015) 0.75
Minimally invasive posterior cervical decompression using tubular retractor: The technical note and early clinical outcome. Surg Neurol Int (2014) 0.75
Operative outcomes for cervical degenerative disease: a review of the literature. ISRN Orthop (2012) 0.75
Analysis of the outcome in patients with cervical spondylotic myelopathy, undergone canal expansive laminoplasty supported with instrumentation in a group of Indian population - a prospective study. Int J Spine Surg (2016) 0.75
The 100 Most Influential Articles in Cervical Spine Surgery. Global Spine J (2015) 0.75
C4 anterior cervical corpectomy with fusion for cervical spondylotic myelopathy. Eur Spine J (2013) 0.75
Most Cited Publications in Cervical Spine Surgery. Int J Spine Surg (2017) 0.75
Why Does C5 Palsy Occur After Prophylactic Bilateral C4-5 Foraminotomy in Open-Door Cervical Laminoplasty? A Risk Factor Analysis. Global Spine J (2017) 0.75
Prognosis of posterior osteophyte after anterior cervical decompression and fusion in patients with cervical spondylotic myelopathy using three-dimensional computed tomography study. Eur Spine J (2016) 0.75
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev (1995) 9.31
Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J Biol Chem (1968) 6.28
Purification and properties of bacterial chondroitinases and chondrosulfatases. J Biol Chem (1968) 5.66
Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene (2010) 4.81
Amino acid sequence of the human fibronectin receptor. J Cell Biol (1987) 4.08
Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci (2000) 3.73
Role of citron kinase as a target of the small GTPase Rho in cytokinesis. Nature (1998) 3.55
Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab (2001) 3.43
Autoregulation of I kappa B alpha activity. Proc Natl Acad Sci U S A (1994) 3.24
Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev (1997) 3.23
Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry (2007) 3.12
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature (1997) 3.07
Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol (1995) 2.91
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature (1998) 2.88
Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J (1985) 2.69
A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. Proc Natl Acad Sci U S A (2000) 2.64
Neck and shoulder pain after laminoplasty. A noticeable complication. Spine (Phila Pa 1976) (1996) 2.61
cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci U S A (1986) 2.58
Evaluation of monensin toxicity in the horse. J Am Vet Med Assoc (1976) 2.56
Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke (2001) 2.51
Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J (2000) 2.48
Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes (1999) 2.47
Pattern electrical stimulation of the human retina. Vision Res (1999) 2.35
Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol (1994) 2.28
Arginine-glycine-aspartic acid adhesion receptors. Methods Enzymol (1987) 2.25
Membrane hyperpolarization inhibits agonist-induced synthesis of inositol 1,4,5-trisphosphate in rabbit mesenteric artery. J Physiol (1992) 2.20
A detailed linkage map of medaka, Oryzias latipes: comparative genomics and genome evolution. Genetics (2000) 2.19
Frequency and stability of chromosomal integration of adenovirus vectors. J Virol (1999) 2.18
Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med (1991) 2.17
Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2). Proc Natl Acad Sci U S A (1999) 2.15
Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b. J Trauma (1998) 2.15
Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant (2000) 2.15
New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology (2005) 2.14
The influence of p-nitrophenyl beta-d-xyloside on the synthesis of proteochondroitin sulfate by slices of embryonic chick cartilage. J Biochem (1973) 2.08
PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem (1999) 2.07
Clinical features of a new disease concept, IgG4-related thyroiditis. Scand J Rheumatol (2013) 2.05
Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun (1998) 2.04
Nucleotide sequence of the CLS4 (CDC24) gene of Saccharomyces cerevisiae. Gene (1987) 2.00
Pulmonary artery disease in Takayasu's arteritis: angiographic findings. AJR Am J Roentgenol (1992) 1.96
Eyelid reconstruction using a hard palate mucoperiosteal graft combined with a V-Y subcutaneously pedicled flap. Br J Plast Surg (2001) 1.96
Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke (2000) 1.94
Possible relationship of a 36-megadalton Salmonella enteritidis plasmid to virulence in mice. Infect Immun (1985) 1.91
Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke (1995) 1.90
In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob Agents Chemother (1989) 1.90
Tremorgenic toxins from Aspergillus fumigatus Fres. Chem Pharm Bull (Tokyo) (1971) 1.88
Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation (1999) 1.88
Calcium-sensitive cls4 mutant of Saccharomyces cerevisiae with a defect in bud formation. J Bacteriol (1986) 1.87
Structural analysis of chick-embryo cartilage proteoglycan by selective degradation with chondroitin lyases (chondroitinases) and endo-beta-D-galactosidase (keratanase). Biochem J (1980) 1.86
Formation of three types of disulfated disaccharides from chondroitin sulfates by chondroitinase digestion. J Biol Chem (1968) 1.86
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology (1992) 1.85
Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res (2000) 1.82
Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J Natl Cancer Inst (1997) 1.81
Vitronectin--a major cell attachment-promoting protein in fetal bovine serum. Exp Cell Res (1985) 1.81
The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes (1996) 1.72
Protocadherins: a large family of cadherin-related molecules in central nervous system. EMBO J (1993) 1.72
A remote monitoring system for patients with implantable ventricular assist devices with a personal handy phone system. ASAIO J (1999) 1.70
Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury. Kidney Int (2006) 1.70
p190-B, a new member of the Rho GAP family, and Rho are induced to cluster after integrin cross-linking. J Biol Chem (1995) 1.70
Structural study of phosphomannan of yeast-form cells of Candida albicans J-1012 strain with special reference to application of mild acetolysis. Arch Biochem Biophys (1989) 1.70
Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology (2006) 1.68
FV-4: a new gene affecting the splenomegaly induction by Friend leukemia virus. Jpn J Exp Med (1975) 1.67
A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol (2001) 1.67
Long-term follow-up results of laminectomy for cervical myelopathy caused by ossification of the posterior longitudinal ligament. J Neurosurg (1998) 1.67
The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol (1988) 1.65
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Diabetologia (2011) 1.63
A large chondroitin sulfate proteoglycan (PG-M) synthesized before chondrogenesis in the limb bud of chick embryo. J Biol Chem (1986) 1.62
Microbial electrode BOD sensors. Biotechnol Bioeng (1977) 1.62
Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia. N Engl J Med (1981) 1.61
Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. Cancer (1996) 1.61
An alternative cytoplasmic domain of the integrin beta 3 subunit. Proc Natl Acad Sci U S A (1989) 1.61
Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis. Biochem Biophys Res Commun (2001) 1.61
The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. J Biol Chem (1999) 1.59
Histopathological aspects of dural arteriovenous fistulas in the transverse-sigmoid sinus region in nine patients. Neurosurgery (1997) 1.59
Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg (1998) 1.59
Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. Ophthalmology (1993) 1.58
Fv-2 locus controls the proportion of erythropoietic progenitor cells (BFU-E) synthesizing DNA in normal mice. Cell (1980) 1.57
Isolation of two forms of basement membrane proteoglycans. J Biol Chem (1985) 1.55
Choice of surgical treatment for multisegmental cervical spondylotic myelopathy. Spine (Phila Pa 1976) (1985) 1.55
Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation (1994) 1.55
PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients. Leukemia (2008) 1.53
The prognosis of surgery for cervical compression myelopathy. An analysis of the factors involved. J Bone Joint Surg Br (1989) 1.53
Myelopathy hand. New clinical signs of cervical cord damage. J Bone Joint Surg Br (1987) 1.53
Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes (1995) 1.51
cDNA sequences from the alpha subunit of the fibronectin receptor predict a transmembrane domain and a short cytoplasmic peptide. J Biol Chem (1986) 1.51
Tumor-detecting capacity and clinical usefulness of SPIO-MRI in patients with hepatocellular carcinoma. J Gastroenterol (2000) 1.50
Central nervous system complications after cardiac surgery: a comparison between coronary artery bypass grafting and valve surgery. Anesth Analg (1993) 1.49
Characteristics of the operon for a putrescine transport system that maps at 19 minutes on the Escherichia coli chromosome. J Biol Chem (1993) 1.49
Concentrations of pyridinoline and deoxypyridinoline in joint tissues from patients with osteoarthritis or rheumatoid arthritis. Ann Rheum Dis (1996) 1.49
NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. J Biol Chem (2000) 1.48
DNA relatedness among Erysipelothrix rhusiopathiae strains representing all twenty-three serovars and Erysipelothrix tonsillarum. Int J Syst Bacteriol (1992) 1.47
Morbidity and mortality of hospitalized patients after the 1995 Hanshin-Awaji earthquake. Am J Emerg Med (1999) 1.47
Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation (1993) 1.47
Congenital hypopituitarism with hypoplasia of the anterior pituitary gland and a normal posterior pituitary lobe. Acta Paediatr (1995) 1.46
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Can intramedullary signal change on magnetic resonance imaging predict surgical outcome in cervical spondylotic myelopathy? Spine (Phila Pa 1976) (1999) 1.46
Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology (1994) 1.46
Characterization of phosphomannan-protein complexes isolated from viable cells of yeast and mycelial forms of Candida albicans NIH B-792 strain by the action of Zymolyase-100T. Arch Biochem Biophys (1986) 1.46